CRINETICS PHARMACEUTICALS, INC.

CRNX NASDAQ
23.44
+0.25
+1.08%
After Hours: 23.44 0 0.00% 16:29 06/20 EDT
Open
23.53
Prev Close
23.19
High
24.42
Low
22.92
Volume
35.35K
Avg Vol (3M)
57.83K
52 Week High
42.00
52 Week Low
19.23
% Turnover
0.16%
Market Cap
515.87M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers CRINETICS PHARMACEUTICALS, INC. CRNX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Crinetics Pharmaceuticals, Inc. is a clinical stage pharmaceutical company. The Company is focused on the discovery and development of drugs to treat specialty endocrine diseases and endocrine-related tumors. It develops a pipeline of oral nonpeptide chemical entities that target peptide G protein coupled receptors (GPCRs) for the treatment of endocrine diseases. The Company’s lead product candidate is CRN00808 developed for the treatment of acromegaly. It also develops two other product candidates CRN02481 for hyperinsulinemia, and CRN01941 for the treatment of neuroendocrine tumors. CRN02481 and CRN01941 are both oral nonpeptide somastatin receptors that are in the pre-clinical stages of development. The company also conducts research programs on developing nonpeptide products for the treatment of Cushing’s disease.
MORE >

Recently

Name
Price
%Change